LOX and breast carcinoma: In addition, the roles of other miRs in suppressing LOX family members in various types of cancer have been revealed, including in neck squamous cell carcinoma [63], prostate cancer [64], renal cell carcinoma [65], breast cancer [66], anaplastic thyroid cancer [67], lung squamous cell carcinoma [68], non-small cell lung cancer [69], and giant-cell carcinoma of the lung [70] (Table 5).